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Abstract 
For precision medicine to be implemented through the lens of in silico technology, it is imperative that 
biophysical research workflows offer insight into treatments that are specific to a particular illness and 
to a particular subject. The boundaries of precision medicine can be extended using multiscale, 
biophysics-centred workflows that consider the fundamental underpinnings of the constituents of cells 
and tissues and their dynamic environments. Utilising numerical techniques that can capture the broad 
spectrum of biological flows within complex, deformable and permeable organs and tissues is of 
paramount importance when considering the core prerequisites of any state-of-the-art precision 
medicine pipeline. In this work, a succinct breakdown of two precision medicine pipelines developed 
within two VPH projects are given. The first workflow is targeted on the trajectory of Alzheimer’s 
Disease, and caters for novel hypothesis testing through a multicompartmental poroelastic model which 
is integrated with a high throughput imaging workflow and subject-specific blood flow variability 
model. The second workflow gives rise to the patient specific exploration of Aortic Dissections via a 
multi-scale and compliant model, harnessing imaging, CFD and dynamic boundary conditions. Results 
relating to the first workflow include some core outputs of the multiporoelastic modelling framework, 
and the representation of peri-arterial swelling and peri-venous drainage solution fields. The latter 
solution fields were statistically analysed for a cohort of thirty-five subjects (stratified with respect to 
disease status, gender and activity level). The second workflow allowed for a better understanding of 
complex aortic dissection cases utilising both a rigid-wall model informed by minimal and clinically 
common datasets as well as a moving-wall model informed by rich datasets. 
Key words: Alzheimer’s Disease, Aortic Dissection, Computational Fluid Dynamics, Dementia, 
Glymphatic system, Haemodynamics, Multiple-Network Poroelastic Theory, Virtual Physiological 
Human (VPH) 
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1. INTRODUCTION 
For precision medicine to be implemented within the paradigm of in silico technology, it is imperative 
that biophysical research workflows offer insight into treatments that are both disease and subject-
specific. The boundaries of precision medicine can be extended using such multiscale workflows, but 
it is imperative that they are able to consider the fundamental underpinnings of the constituents of cells 
and tissues and their dynamic environments. A secondary motivation to this work is also the rising 
ethical concerns surrounding animal experimentation is cultivating growing interest in alternative 
methods, such as in vitro or in silico technologies [1]. The utilisation of numerical techniques that can 
capture the broad spectrum of biological flows within complex three-dimensional, deformable and 
permeable organs and tissues is of paramount importance when considering the core prerequisites of 
any state-of-the-art precision medicine pipeline. In this manuscript, two pipelines that were developed 
within two VPH projects are described, namely VPH-Dementia Research Enabled by IT (VPH-
DARE@IT, www.vph-dare.eu) and VPH-Cardiovascular Simulation and Experimentation for 
Personalised Medical Devices (VPH-CaSE, www.vph-case.eu).  Within VPH-DARE@IT, one of the 
core objectives of the project was to extend the understanding of dementia (with a focus on the trajectory 
of Alzheimer’s Disease through novel hypothesis testing) in addition to promoting earlier differential 
diagnosis through a unified multi-scale modelling approach (revolving around a multicompartmental 
poroelastic model) that fully accounts for environmental influences on biophysics, physiology, novel 
clinical biomarkers and lifestyle. VPH-CaSE focused on cardiovascular medical devices and offered a 
highly integrated knowledge-exchange pipeline revolving around cardiac tissue function and cardiac 
support, cardiovascular haemodynamics and image-based diagnosis and imaging quality assurance. 
Through this pipeline, patient specific explorations of Aortic Dissections were performed, via a multi-
scale and compliant model, harnessing imaging, CFD and dynamic boundary conditions.  
 
1.1 Alzheimer’s Disease (AD) and the Glymphatic system 
The global cost of dementia is expected to reach $2 trillion by 2030. By 2050, it is estimated that over 
150 million people will be living with dementia [2]. Alzheimer’s Disease (AD) accounts for 
approximately 70% of all dementia cases [3], and is characterized by a heterogeneous mixture of 
multiple age-related neurodegenerative factors and vascular related pathologies. The hallmark 
pathological features of the disease are the extracellular deposition of amyloid-β (Aβ) peptide into 
parenchymal senile plaques or within the walls of arteries and capillaries, in addition to the aggregation 
of hyperphosphorylated tau into intracellular neurofibrillary tangles and neuropil threads [4,5]. 
Evidence suggests that AD may be a vascular disorder [6,7], caused by impaired cerebral perfusion 
(characterized by reduction in both total and regional cerebral blood flow (CBF) [8]) [7,9], which is 
observable at the prodromal stages of the disease [10,12]. Hypoperfusion can compromise the 
oxygenation of neurons, negatively affect the synthesis of proteins required for memory and learning 
and subsequently lead to neuronal dysfunction or death [13,14]. During this early stage of the disease, 
AD may present itself as mild cognitive impairment (MCI), an intermediate state between normal 
ageing and dementia. Traditionally, MCI has been defined as a condition whereby an individual 
experiences memory loss to a greater extent than that expected for that age but does not meet the criteria 
for dementia [16]. Clearance of Aβ at the level of the blood–brain barrier (BBB), an important part of 
the neurovascular unit (NVU), is also important in preventing plaque accumulation [15].  
The interstitial fluid (ISF) of the brain is tasked with providing the environment for healthy 
neuronal functioning. It is therefore vital that the maintenance of the ISFs volume and composition is 
maintained. This requires the regulation and removal of water, ions and both nutritive and waste 
products. The parenchyma of the central nervous system is devoid of lymphatic vessels [17], which in 
other organs, is critical for maintaining tissue homeostasis [18]. The way the brain maintains ISF 
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homeostasis is currently unclear [19]. Iliff et al. [20] propose a glymphatic pathway, whereby 
cerebrospinal fluid (CSF) enters the brain via the paravascular spaces along the penetrating arteries on 
the surface of the brain (peri-arterial spaces), subsequently passing through the astroglial end-feet and 
enters the parenchymal tissue where it mixes with ISF and exits (dragging along waste products such 
as Aβ) via peri-venous spaces. Interestingly, ageing and activity (such as sleep) are also known to 
influence the functioning of the glymphatic system [21,22].      
The intricate nature of the glymphatic system is further amplified by the complex, and broad 
spectrum of disorders that constitute dementia. It is therefore important to define novel clinically 
relevant biomarkers that can capture the underlying transport phenomena of the glymphatic system, 
whilst also being generic enough in order to be interrogated via large-scale statistical analyses. In this 
work, the precision medicine workflow allows for the peri-arterial swelling and peri-venous drainage 
(outputs of the in silico model) to be explored for different genders and activity levels, as these 
components are central to the glymphatic system hypothesis. This approach allows for a previously 
unexplored understanding of the disease trajectory (from MCI to AD), and extends the approach used 
to interrogate the NVU in the region of the hippocampus [55]. The central driver of the in silico model 
presented here is a surrogate model that outputs arterial blood flow waveforms that are used as boundary 
conditions whilst taking into account the otherwise challenging nature of LEFs [26] and subject profiles. 
In addition, an imaging pipeline is used to further personalise the workflow via the acquisition of a 
subject-specific atlas of ISF/CSF permeability within the parenchymal tissue; and also, the accurate 
representations of the cerebroventricular geometries.  
1.2 Aortic Dissection (AoD) 
Aortic dissection is an extremely severe vascular condition with high mortality rates. With an incidence 
of 3-4 cases per 100,000 every year in the United Kingdom and United States, it represents the most 
common aortic emergency, more frequent than ruptured aneurysms [29].  
AoD is characterized by the separation of the layers of the aortic wall: a tear in the intima layer 
allows the blood to flow within the aortic wall inducing the formation of two flow channels, the true 
(TL) and false lumen (FL), separated by an intimal flap (IF) [30]. Classification and medical 
management of AoDs is based on the anatomical location of the dissection: those involving the 
ascending aorta (Type- A) are more dangerous and are treated surgically as soon as possible [31]. AoDs 
not involving the ascending aorta are commonly managed with best medical treatment (BMT) in the 
absence of complications, such as rupture, end-organ malperfusion, refractory pain or hypertension. 
They include the ‘classic’ Type-B dissections (involving only the descending thoracic aorta), the ‘Arch 
B’ dissections (involving the aortic arch and the descending thoracic aorta) [32] and the ‘residual post 
Type-A’ dissections (involving the aortic arch and the descending thoracic aorta after the surgical 
replacement of the ascending thoracic aorta). However, BMT alone is associated with poor long-term 
prognosis, with invasive re-intervention in up to 50% of the patients [33]. The identification of patients 
at risk of developing adverse events at an early stage would allow them to undertake pre-emptive 
endovascular treatment (TEVAR) in the acute or subacute phase, avoiding the challenges of chronic 
repair procedures [34].  
Management and treatment of AoD are highly patient-specific and morphological features, flow 
patterns, pressures, velocity and shear rates are extremely important features for this pathology. Hence, 
patient-specific computational fluid-dynamics (CFD) may lead to objective and quantifiable predictors 
of adverse outcomes and assist the clinical decision-making around the treatment of Type-B AoDs 
[35,36].  
In a clinical scenario, the datasets used to inform the CFD models are often incomplete and 
noisy, and practical, ethical and physical reasons prevent the acquisition of complete datasets necessary 
to construct fully ‘patient-specific’ models [37]. Hence, adequate modelling assumptions need to be 
made to ‘fill the gaps’. A challenging and important task is the description of the boundary conditions 
(BSs); state-of-the-art vascular CFD models adopt 3-elements Windkessel models to approximate the 
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downstream vasculature not included in the 3D model, with parameters calibrated to represent the 
specific patient [38].  In the case of AoDs, the task of the modeller is further complicated by the complex 
geometries and by the compliance and motion of the arterial wall, which can significantly affect the 
fluid dynamics results [39].  
 
 
1.3 Outline of the article 
This paper briefly describes two consolidated pipelines that were developed within the life-cycle of the 
VPH-DARE@IT (focused on Alzheimer’s Disease) and VPH-CaSE projects (focused on Aortic 
Dissection). This section commenced by outlining the motivation behind their development, along with 
a brief introduction to Dementia, Alzheimer’s Disease and the glymphatic system. Subsequently, a brief 
introduction to Aortic Dissection was made, along with its management and treatment, and finally the 
motivation behind developing the consolidated pipeline. §1 was concluded with a brief introduction to 
multiple-network poroelastic theory (MPET). The essential breakdown of the methodology behind the 
full implementation scheme for both pipelines will follow in §2 (highlighting the integrated nature of 
the workflows embedded within the VPH-DARE@IT and VPH-CaSE research pipelines), the clinical 
data collection protocol used to extract the subject-specific data used in both pipelines, and finally the 
statistical tests used to analyse the MPET results. In §3, results relating to both pipelines are briefly 
discussed. For the first pipeline (VPH-DARE@IT), MPET simulations are presented (based on one 
control and one MCI subject) in order to depict the nature of the solution fields that are obtainable at 
the level of the parenchyma. Subsequently, a Kruskal-Wallis H-test (to determine if there were 
differences in peri-arterial swelling and peri-venous drainage in the cortical grey matter between the 
groups considered, during two levels of activity) and Wilcoxon signed-rank test (to determine whether 
there was no statistically significant median decrease in peri-arterial swelling and peri-venous drainage 
in the cortical grey matter when subjects lowered their activity level) was conducted for a cohort of 35 
subjects. For the second pipeline (VPH-CaSE), two computational templates for AoD interrogation are 
described: (i) a rigid-wall modelling approach based on non-invasive datasets commonly collected for 
AoD monitoring, in which the aortic compliance is approximated with a lumped-parameter, and (ii) a 
moving-wall modelling approach informed by non-invasive but rich multimodal datasets that include 
non-routine displacement data.  The conclusions to the paper are outlined in §4. 
 
2. METHODOLOGY 
2.1 Clinical datasets  
The subject-specific datasets used in the MPET modelling of this paper were collected as part of the 
VPH-DARE@IT project (www.vph-dare.eu), and prospective data collection was conducted at the 
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Camillo, Lido di Venezia, Italy. This 
study, including a total of 103 people, was approved by the joint ethics committee of the Health 
Authority Venice 12 and the IRCCS San Camillo (Protocol number 2014.08), and all participants gave 
informed consent prior to participation in the study. A cohort of 35 subjects (n = 20 CHC, n = 15 MCI) 
was picked from the 103 available subjects. This smaller cohort can be stratified into 4 groups, 
considering males (M) and females (F): CHCM (n = 8, age 69.4 ± 8.5 years), CHCF (n = 12, age 72.5 ± 
5.7 years), MCIM (n = 8, age 75.4 ± 5.0 years) and MCIF (n = 7, age 74.9 ± 8.2 years).  
The clinical datasets used for the AoD modelling were collected as part of the EU project VPH-
CaSE (www.vph-case.eu) and consisted of 3 patients with chronic AoD, acquired as part of an ethically 
approved protocol at San Camillo-Forlanini Hospital (Rome, Italy, Prot. n.: 900/CE Lazio 1), and 
included contrast-enhanced computed tomography (CT) scans, cardiac Doppler ultrasound (US) 
measurements, non-invasive blood pressure (BP) measurement, and invasive intra-aortic BP 
measurements. The dataset of a patient with a chronic Type-B AoD was acquired from the Leeds 
Teaching Hospitals (NHS Health Research Authority, ref: 12/YH/ 0551, Leeds Teaching Hospitals 
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NHS Trust, ref: 788/RADRES/16), and included: non-invasive BP measures, CT scans, high spatial 
and temporal resolution electrocardiogram-gated cine-imaging sequences (cine-MRI) and through-
plane phase-contrast velocity mapping images (PC-MRI). 
 
 
2.3 Pipeline developed for investigating Alzheimer’s Disease 
The Alzheimer’s Disease pipeline relies on a computational model making use of poroelastic equations 
describing fluid flow through a porous medium coupled with deformation of the solid matrix [23-25]. 
These relationships central to the theory relate the total stress, volumetric fluid flux and fluid content to 
the primary variables of the two-field formulation, namely the solid matrix displacement and scalar pore 
pressure. The MPET model was used to conduct mechanistic modelling of fluid transport through the 
brain parenchyma.  
For a research workflow promoting precision medicine, it’s imperative that the patient’s 
history, lifestyle and environmental factors (LEFs) are also considered. In this work, a workflow was 
used to garner a more detailed understanding of the underlying reasons for the variability in disease 
trajectory, by incorporating LEFs, and interrogating the results based on novel biomechanistic 
biomarkers that are derived within the realm of fluid transport in the brain. The MPET model allows 
for the simultaneous solution of continuity and momentum conservation equations, in four 
interconnected fluid compartments, within a deformable solid matrix (the parenchymal tissue)., and can 
capture the biomechanical behaviour (brain tissue displacement, pore pressure, filtration velocity, 
swelling and drainage of the fluid for each compartment) of perfused tissue. For a detailed description 
Figure 1. Subject-specific imaging pipeline for acquiring subject-specific cerebroventricular geometries (that 
are discretised using tetrahedral elements) and permeability tensor maps (top left), personalised cerebral blood 
flow waveforms (top right) that are fed into the arterial compartment of the MPET solver (bottom right), in 
the form of a Neumann boundary condition. For the MPET system, the solid matrix represents brain 
parenchyma, and the communicating fluid phases considered are an arterial network (a), an arteriole/capillary 
network (c), a CSF/ISF network (mixing the two has been proposed as a candidate for better understanding 
peri-venous efflux [19] (e) and a venous network (v).  A representation of typical solution fields is depicted 
(bottom left). Ageing and lifestyle related patient-specific boundary conditions are generated following the 
data collection and subject-based model parameterisation. The personalisation of the lumped parameter 
circulation model was accelerated via a surrogate model to approximate its input-output response. LPCM = 
Lumped parameter circulation model, CAM = cerebral autoregulation model.  
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on the boundary conditions used, the mesh independence study and the parameters used in this study, 
the reader is referred to work by Vardakis et al. [55] and Guo et al. [28].  
The modelling pipeline presented here is personalised for individual subjects on three levels: 
cerebroventricular geometries (accompanied by the relevant meshes) were extracted from structural 
MR images; spatial maps of CSF/ISF compartment permeability tensors were estimated from diffusion 
MR data; and arterial blood flow waveforms, used as cortical surface boundary conditions, were derived 
from measurements of blood pressure, flow velocity, and other inputs as described in Guo et al [28]. 
A key component of the subject-specific modelling pipeline (see Figure 1) is the personalised 
boundary conditions for arterial blood flow. Subject-specific, 24-hour blood flow variability is obtained 
through a combination of ambulatory blood pressure measurements, clinical ultrasound flow 
measurements, and mathematical modelling. A lumped parameter circulation model (LPCM) [40] is 
used to simulate continuous arterial blood flow and translate the spot measurements collected every 15 
min during the day and every 30 min during the night, to continuous waveforms of arterial blood flow. 
Two specific measurements were chosen from the 24-hour recording as indicative of the subject’s 
activity –high activity (e.g. exercise) identified by highest peak values of arterial blood flow within 24-
hours; and low activity (e.g. sleep) identified by the lowest peak values. The waveforms corresponding 
to these two activity states were used in the subject-specific modelling of this manuscript as boundary 
conditions for the arterial compartment at the cortical surface (four waveforms were calculated at every 
time point, which are the ICA blood to the left and right cerebrum, and the vertebral artery blood to the 
left and right cerebellum). The reader is directed to two relevant publications for further details 
regarding the personalised boundary conditions and the protocol of their application in the MPET 
numerical template [28, 40].  
Each subject that was analysed had several measurement modalities collected as part of the 
study, such as: lifestyle questionnaires and neuropsychological tests, whole brain MR imaging, clinical 
ultrasound flow imaging, portable Holter recordings of blood pressure, and actigraph measured activity 
levels. Further details can be found in Guo et al. [28]. T1-weighted and diffusion-weighted MR images 
were processed via a fully automated workflow to create accurate 3D whole-brain meshes and 
permeability tensor maps (PTMs) of the parenchyma (translating to a heterogeneous and anisotropic 
permeability field for the CSF/ISF compartment) were extracted using the workflow described in detail 
in Guo et al. [28]. The consolidated workflow described here, has been embedded within the MULTI-
X (www.multi-x.org) cross-domain research platform. Such a platform must address the issues 
revolving around scalability, reproducibility, flexibility interoperability, fast prototyping, workflow 
management, data management, data visualisation, licensing and IP management, cost assessment, 
security and compliance, and importantly, collaboration [41].   
 
2.4 Pipeline developed for investigating Aortic Dissection 
For the case of AoD, two different in silico explorations were conducted, one, based on the typical 
datasets available to clinicians, the second, based on a rich, multimodal dataset acquired for research 
purposes. In the case of the typical, clinically available information, the monitoring of AoD usually 
involves non-invasive datasets which include contrast-enhanced CT scans, cardiac Doppler US and 
non-invasive BP measurements. In this section, a CFD framework for personalised rigid-wall 
simulation informed by commonly available clinical datasets is presented. 
Figure 2a shows the pipeline followed for the implementation of the computational model. The 
AoD geometry is extracted from contrast-enhanced CT scans using semi-automatic thresholding 
algorithms implemented in the image-processing software Simpleware ScanIP (Synopsys Inc., CA, 
USA). The stroke volume (SV) and heart rate (HR) of the patient are extracted from cardiac US 
measurements and are used to personalise a typical flowrate template curve to be used as inflow 
condition. Model parameters (i.e. Windkessel parameters and aortic compliance) are fine-tuned with a 
personalisation procedure which combines time-dependent simulations on a reduced-order 0D model 
and 3D steady-state simulations, as detailed in [49]. The calibration objectives are: (i) to achieve 
physiological blood flow distribution among the model outlets, and (ii) to obtain the target systolic (Psys) 
and diastolic (Pdia) blood pressures at the inlet, as derived from the non-invasive blood pressure 
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measurements. The fine-tuned parameters are then used in the (geometric) multi-scale CFD model 
(Figure 2a) in which the fluid-structure interaction effects due to the compliance of the aorta are 
modelled via a lumped capacitor (Caorta) proximal to the inlet of the 3D model [50]. More advanced 
patient-specific CFD models that include the motion of the arterial wall require richer multi-modal 
datasets. This section describes a CFD template that employs a moving-boundary method (MBM) to 
account for arterial wall compliance and IF motion in CFD simulations (Figure 2b). The model is 
informed by CT scans, PC-MRI or US flow data, non-invasive BP measurements and by cine-MRI-
derived displacement data. The MBM adopts physiologically-supported calculations based on pressure 
differences and fluid forces in the computational domain along with wall stiffness estimated in different 
regions of the vessel, as detailed in Bonfanti et al. [48]. Reduced-order 0D models and 3D rigid-wall 
simulations are used to calibrate the parameters employed in the compliant model, with the same 
calibration objectives described in the previous section [46].  
For both cases, CFD simulations were solved with ANSYS-CFX 18.0 (ANSYS Inc., PA, USA). 
The Navier-Stokes equations are spatially and temporally discretised with a high-resolution advection 
scheme and a second order implicit backward Euler scheme [47], respectively, using a uniform time-
step of 1 ms, small enough for time-step size-independent results. Further details on the simulation 
settings can be found in Bonfanti et al. [46]. 
 
 
Figure 2: Schematic of the pipelines for the two AoD CFD templates: (a) Rigid-wall models informed by 
minimal datasets, WK3 indicates the Windkessel models coupled at the outlets (see inset) (b) Moving-wall 
models informed by rich datasets, the colour map shows the spatial-varying area compliance of the aorta (CA 
= A/P, A: cross-sectional area variation during the cardiac cycle, P: pressure variation during the cardiac 
cycle), estimated from patient-specific cine-MRI data. The inset shows a cross-section of the ascending aorta 
and a schematic depicting how the displacement  of a node n on the vessel wall is related to the pressure pn 
calculated in the fluid domain and to the stiffness coefficient Kn, according to the moving boundary method 
(MBM). 
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3. RESULTS & DISCUSSION 
3.1 Alzheimer’s Disease 
Figure 3 depicts five typical solution fields arising from the MPET solver for two subjects (79-year-old 
male with MCI and a 73-year-old female cognitively healthy control), namely peri-arterial and peri-
venous swelling, peri-arterial and peri-venous drainage, clearance of CSF/ISF, intracranial pressure 
with overlapping blood velocity vectors. Comparing the results between the control and MCI case, the 
clearance of CSF/ISF is higher for the control, in addition to it being largely segregated to the 
periventricular region.  
Figures 4a-d depicts the results for peri-arterial and peri-venous swelling and drainage in the 
cortical grey matter. These results cover the cohort of 35 subjects (and are stratified with respect to 
gender, disease status and activity level). A Kruskal-Wallis H-test was conducted to determine if there 
were differences in peri-arterial swelling and peri-venous drainage in the cortical grey matter of the 
brain between 4 groups (stratified with respect to gender and disease status), during two levels of 
activity (high and low). A Wilcoxon signed-rank test was used to determine whether there was no 
statistically significant median decrease in peri-arterial swelling and peri-venous drainage in the cortical 
grey matter when CHC and MCI subjects lowered their activity level. This is a novel adaptation MPET 
model. In this example, the focus was on the cortical grey matter. This allows one to interrogate the 
complex pathophysiology of the brain-wide perivascular system (the “glymphatic system”).  Boespflug 
et al. [42] postulated that the enlarged perivascular space (ePVS) is a possible marker of glymphatic 
dysfunction in the AD brain. In this work, the assumption that water diffuses between the perivascular 
spaces and tissue (thereby incorporating the macroscopic effects of aquaporin-4 [43]) [44,45] is 
Figure 3. A selection of MPET results (axial and coronal slices) for the brain parenchyma for two subjects, 
a 79-year-old male with MCI and a 73-year-old female cognitively healthy control. Specifically, results are 
shown for peri-arterial and peri-venous swelling (positive values of the fluid content of the arterial and 
venous MPET compartments), peri-arterial and peri-venous drainage (negative values of the fluid content in 
the same compartments), clearance of CSF/ISF (Darcy velocity of the CSF/ISF compartment), intracranial 
pressure (pore pressure of the CSF/ISF compartment) with overlapping blood perfusion (Darcy velocity of 
the capillary compartment) velocity vectors. (a-c) Coronal section of the brain at the level of the lateral 
ventricles for the MCI subject. (d) An axial slice of the brain (MCI subject), with the intracranial pressure 
of the parenchyma overlapping with the Darcy velocity vectors of the capillary compartment (perfusion). (e-
g) Coronal section of the brain at the level of the cerebral ventricles for the CHC subject. (h) An axial slice 
of the brain (CHC subject), with the intracranial pressure of the parenchyma overlapping with the perfusion 
solution field. The magnitude of the velocity vectors has been halved to improve visibility. All results were 
acquired during a period of high activity.  
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incorporated, and it is assumed that the ePVS in the cortical grey matter occurs as a direct result of the 
peri-arterial swelling (the accumulation of fluid in the arterial compartment). 
 
Figure 4. Box and whisker plots depict the MPET results for peri-arterial swelling (a, b) and peri-
venous drainage (c, d) in left and right hemispheres (LH, RH) for the cohort of 35 subjects. Both 
sets of results are stratified with respect to males and female groups, with raw data points laid over 
a 1.96 SEM (95% confidence interval) in orange and a 1 SD in blue. Means are also shown with an 
orange circle. Raw data is dispersed along the x-direction, for clarity. A Wilcoxon Signed Rank Test 
showed that when comparing the four groups during high and low activity, there were differences 
in the degree of peri-arterial swelling and peri-venous drainage, but these differences were not 
statistically significant.  (e) Kruskal-Wallis H-Test for peri-arterial swelling and peri-venous 
drainage in the cortical grey matter. CHC = Cognitively Healthy Control, MCI = Mild Cognitive 
Impairment, CGM = Cortical Grey Matter, S = swelling, D = drainage, M = male, F = female, HA 
= High Activity, LA = Low Activity.  
e  
Right Hemisphere Left Hemisphere 
HA LA HA LA 
χ2  p χ2  p χ2  p χ2  p 
CGMS 4.74 0.192 4.74 0.192 2.36 0.501 2.44 0.486 
CGMD 5.55 0.136 5.55 0.136 3.77 0.287 3.77 0.287 
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It has been suggested that systemic hypertension can cause stiffening and microvascular distortion of 
vessels, in addition to being associated with reduced capillary density [60]. The trajectory of such a 
clinically relevant problem can be captured using the personalised modelling pipeline presented in this 
work. Microvascular permeability and overall cerebral compliance can be linked within the numerical 
template, thus providing insight (via remodelling processes which account for white matter alterations 
associated with AD) into the influence of lifestyle and environmental factors, and age-dependent 
vascular compliance (through a more detailed understanding of cerebral hypoperfusion [28]) [55]. 
The generic MPET model for perfused parenchymal tissue can be used to provide insight into 
the underlying mechanisms of the NVU in different regions of the brain on similar-sized subject cohorts 
[55], to account for aqueductal stenosis during hydrocephalus [43], provide insight into oedema 
formation within parenchymal tissue [56, 57], offer personalised management of surgical procedures 
that affect the cerebroventricular system (such as endoscopic third and fourth ventriculostomy) [57, 58] 
and may also be applied to the study of other organs [59]. 
 
3.2 Aortic Dissection pipeline 
The multiscale rigid-wall CFD approach was successfully applied to 3 complex cases of AoDs 
involving the descending aorta, with datasets acquired at the San Camillo-Forlanini Hospital (Rome, 
Italy). The proximal lumped-capacitor allowed obtaining reliable blood pressure predictions in the 
rigid-wall models, as proved by the comparison against patient-specific invasive intra-aortic BP 
measurements [49]. Haemodynamic results showed how small tears in the distal IF induce disturbed 
flow in both lumina. Moreover, oscillatory pressures across the IF were often observed in proximity to 
the tears in the abdominal region, which could indicate a risk of dynamic obstruction of the TL. As an 
example, Fig. 5 shows some of the results obtained for one of the patients.  
 
Figure 5: (a) Velocity streamlines at peak systole. High blood velocities, that translate in high wall shear 
stresses, can be noted at the level of the first entry-tear, whereas vortical flow can be observed in the proximal 
part of the false lumen (FL). (b) Pressure difference (∆P) between the true lumen (TL) and the FL calculated 
at three different phases of the cardiac cycle along the dissection. Negative values of ∆P at the level of the 
abdominal aortic branches (next to the location of the tears 2-5) may lead to dynamic compression of the TL 
due to intimal flap (IF) motion and consequently hinder the blood flow in these important branches. (c) 
Oscillatory shear index (OSI) contour map. High OSI values can be seen in the FL indicating disturbed flow. 
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The proposed rigid-wall multiscale approach greatly enhances the haemodynamic information available 
for AoD patients by combining commonly available non-invasive datasets with CFD modelling. 
However, in certain AoD settings, the rigid-wall approximation does not allow an accurate simulation 
of the intra-aortic haemodynamics. This is the case of acute AoD settings, in which the IF motion is 
significant, and of dissections lacking, or with small, re-entry tears [51]. The multiscale compliant 
approach allows accounting for vessel wall motion effects, as shown in a case-study of a Type-B AoD 
with dataset provided by the Leeds Teaching Hospitals [46]. The comparison against MRI-derived flow 
and displacement data (Fig. 6) demonstrated that this approach can accurately represent the aortic 
haemodynamics overcoming the limitations of rigid-wall approaches. 
CFD modelling for AoD can provide valuable insight in the pathology providing information 
impossible to obtain in vivo in a clinical setting. Such information can be used to predict possible 
outcomes, such as FL thromboses - correlated to regions of low velocities and oscillatory wall shear 
stresses (WSS) [52] - or dissection propagation - correlated to areas of elevated WSS [53]. Moreover, 
intra-luminal blood pressure and its imbalance between the TL and FL could give indication on potential 
complications, such as FL expansion and TL collapse [54]. 
The approaches presented in this work can represent the basis to further develop clinical 
applications of CFD models. For instance, to simulate complex surgical procedures [27] and investigate 
the best outcome on a patient-specific basis, especially in those vascular pathologies where treatment 
and management are still a clinical challenge, such as AoD. 
 
 
Figure 6: Compliant CFD model results and patient-specific MRI data: (a) Comparison between the flow rate 
waves in the TL from the CFD model and PC-MRI data. (b) Comparison between the trans-mural pressures 
(TMP) across the IF obtained with the compliant model (solid line) and the IF displacement observed from 2D 
cine-MR images at different time instances (TMP = PTL - PFL, where PTL and PFL are the pressures in the TL 
and FL averaged over a cross-section located at the same level of the 2D cine-MRI slice). It can be noted that 
the direction of the IF displacement agrees well with the sign of the TMP: a positive TMP corresponds with 
the motion of the IF through the FL, whereas a negative TMP relates to the motion of the IF through the TL. 
A rigid model (dashed line) fails to predict the correct TMP. (c) Percentage cross-sectional area variation 
(A%) during a cardiac cycle at the level of the abdominal aorta: comparison between CFD results and 2D 
cine-MRI. A% = (A – A0)/A0, where A is the cross-sectional area of the vessel lumen and A0 is the lowest 
cross-sectional area of the vessel lumen throughout a cardiac cycle. 
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3.3 Lessons learned and commonalities  
Both biophysical workflows presented in §2.3 and §2.4 tackle questions in two areas of the human body 
with unique vascular requirements and underlying pathophysiological cascades. This, however, does 
not imply disparate requirements for the workflows themselves. Both share the need for highly 
personalised blood flow boundary conditions (informed by LEFs), and very accurate geometric 
representations of the volumes that both numerical models (MPET and CFD) ultimately depend upon. 
Importantly, both workflows can cope with large, complex multi-modal datasets that provide a template 
to conduct high-throughput data analysis of the resultant numerical solutions. These can then be defined 
as important clinical biomarkers in the early differential diagnosis and trajectory of AD, and in the 
understanding of the pathological cascade driving AoD. Both research workflows can be extended and 
further validated in order to develop and disseminate novel integrative modelling strategies that unravel 
the complexity of unexplored vascular disorders and help innovate, integrate and better manage 
complex and stratified subject profiles based on the principles of evidence-based medicine.  
4. CONCLUSIONS 
This work showcases two successful VPH technologies that were developed in close collaboration with 
clinicians and meet the requirements of being able to embed themselves in state-of-the-art precision 
medicine research platforms (such as MULTI-X). These highly integrated in silico centric workflows 
are well placed in answering clinical quandaries associated within their respective domains 
(Alzheimer’s Disease and Aortic Dissection), in addition to offering perspective clinical solutions (or 
treatment options) to challenging individual cases through the incorporation of a multitude of 
personalised data profiles.  
The first study was developed through the VPH-DARE@IT project and incorporates a novel three-
dimensional multicompartmental poroelasticity model for perfused parenchymal tissue coupled with an 
automated image-based model personalization workflow, and a subject-specific blood flow variability 
model. A cohort of 35 subjects was used to test the consolidated pipeline in order to provide insight into 
the underlying mechanisms of the glymphatic system in the cortical grey matter of the brain, and to 
ascertain whether physical activity would have an influence in both peri-arterial swelling and peri-
venous drainage. The second study was developed through the VPH-CaSE project and combines two 
sophisticated subject-specific multi-scale flow models that utilise both a rigid-wall model informed by 
minimal datasets and a moving-wall model informed by rich datasets. 
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